Drugs / CJ-40001
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03542916 | Oct → Nov 2014 | — | HK inno.N Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CJ-40001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03542916 ↗ |
| Known as | darbepoetin alfa | “the test (CJ-40001) and reference (NESP®) versions of darbepoetin alfa following a single subcutaneous (SC) or intravenous (IV) administration in healthy male subjects.” PMID 30506495 ↗ Feb 2019 |
| Route | Subcutaneous | “subcutaneous (SC)” PMID 30506495 ↗ Feb 2019 |